首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   63485篇
  免费   6690篇
  国内免费   4810篇
耳鼻咽喉   495篇
儿科学   611篇
妇产科学   599篇
基础医学   7430篇
口腔科学   1218篇
临床医学   8511篇
内科学   9963篇
皮肤病学   620篇
神经病学   3564篇
特种医学   2258篇
外国民族医学   52篇
外科学   6456篇
综合类   11241篇
现状与发展   19篇
一般理论   5篇
预防医学   4428篇
眼科学   1873篇
药学   6904篇
  39篇
中国医学   3473篇
肿瘤学   5226篇
  2024年   270篇
  2023年   1179篇
  2022年   2742篇
  2021年   3441篇
  2020年   2613篇
  2019年   2265篇
  2018年   2258篇
  2017年   2102篇
  2016年   1990篇
  2015年   2985篇
  2014年   3716篇
  2013年   3167篇
  2012年   4915篇
  2011年   5289篇
  2010年   3144篇
  2009年   2432篇
  2008年   3353篇
  2007年   3214篇
  2006年   3164篇
  2005年   3112篇
  2004年   2037篇
  2003年   1977篇
  2002年   1635篇
  2001年   1396篇
  2000年   1438篇
  1999年   1645篇
  1998年   1005篇
  1997年   968篇
  1996年   702篇
  1995年   647篇
  1994年   651篇
  1993年   397篇
  1992年   566篇
  1991年   428篇
  1990年   389篇
  1989年   329篇
  1988年   318篇
  1987年   256篇
  1986年   217篇
  1985年   181篇
  1984年   99篇
  1983年   60篇
  1982年   45篇
  1981年   41篇
  1980年   19篇
  1979年   42篇
  1978年   15篇
  1977年   14篇
  1964年   7篇
  1936年   8篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
R Hu  C Beck  Y B Chang  L J DeGroot 《Autoimmunity》1992,12(2):103-106
Inheritance of Graves' disease has been linked to the HA-DR3 gene product which may function in some specific way in antigen presentation. To determine whether the first extracellular domain of this protein, which is specifically involved in antigen presentation, has the same sequence in patients with Graves' disease and in normal individuals, we have amplified the second exon using the polymerase chain reaction, and then cloned and sequenced the DNA segment. In eight subjects with Graves' disease, sequences identical to prototypic reported sequence for DRB1*0301 were recovered, and in two individuals sequences varied by a few nucleotides, leading to 1-3 amino acid substitutions which did not occur in a pattern. Sequences identical to the prototypic sequence known as DRB3*0101, also previously known as DRw52, were also recovered. Thus the HLA-DRB1 and B3 genes present in patients with autoimmune disease appear to be the same as those present in the general population. These observations indicate that a unique allele is not present in patients with autoimmune disease, but rather that the normal DR3 allele itself, in a manner yet to be described, increases the probability of developing autoimmune thyroid disease.  相似文献   
32.
本文报告了经手术病理证实的53例甲状腺肿瘤,均作了甲状腺造影和B超检查.通过比较分析,我们认为造影对确定肿瘤的良、恶性以及延伸到胸骨后的异位甲状腺肿瘤有其优越性,是一项有效的检查方法;超声则能准确地判断肿瘤的囊、实性,适合碘过敏患者的检查.两种检查各有特点,配合使用有利于对甲状腺肿瘤的诊断和治疗.  相似文献   
33.
柠檬月亮     
明月的公司叫MOONRIVER,不知道的人总以为那些带着粗糙划痕的石壁圈住的是一个咖啡厅,其实不是。屋子里只有素色的窗帘和柔软的沙发,茶几上没有咖啡,但永远放着新鲜的柠檬水,明月接待客 从不做笔录,优质的采访机放在不被注意的地方,工作的时候,电源信号灯轻轻闪烁,明明灭灭。  相似文献   
34.
帕金森病立体定向手术并发脑内出血的原因分析   总被引:2,自引:0,他引:2  
目的:探讨帕金森病立体定向手术颅内出血并发症原因及对策。方法:自1999年4月至2003年3月我们对药物治疗效果不理想的510例帕金森病病人行立体定向毁损手术,术后出现颅内出血9例,其中毁损灶出血3例,穿刺道出血6例。结果:手术治疗4例.保守治疗5例。术后意识恢复但遗留偏瘫4例,经非手术治疗5例.恢复良好,未遗留明显功能障碍。全组无死亡病例。结论:采用磁共振结合微电极导向提高靶点定位精确度,减少微电极记录针道数,降低毁损温度,重视围手术期处理等措施,有助于降低颅内出血并发症的危险。  相似文献   
35.
36.
乳腺囊性增生病癌变过程中部分因素变化的意义   总被引:3,自引:0,他引:3  
检测乳腺囊性增生病(FCD)经不典型增生到癌变部分因素的变化。结果提示:从因明显FCD症状活检至癌变为2~10年;从Ⅱ级以上不典型增生到临床癌变需2~7年;癌变率为3.1%。FCD患者存在性激素分泌调控失常,血浆雌激素和催乳素含量增加,导致上皮细胞增生。乳腺一般性增生细胞的DNA含量和超微结构与正常乳腺上皮细胞相似;无肿瘤相关抗原及异常基因产物表达。而发生在一般性增生基础上的不典型增生则呈现细胞基因物质DNA含量增加,部分为超4C的多倍体细胞;同时出现细胞膜和细胞核超微结构异常;雌激素受体含量增加,对性激素的依赖性和敏感性增强;部分不典型增生细胞出现胚胎性肿瘤相关抗原和异常基因产物表达。随不典型增生程度加重至乳腺癌,上述诸因素的变化趋势具有明显规律性。提示FCD上皮细胞从一般性增生经不典型增生至乳腺癌为细胞生物学连续逐渐变化的过程。部分不典型增生细胞中具有癌倾向的细胞生物学行为异常和表型变化与乳腺癌发生密切相关。细胞核DNA含量等异常变化及程度可作为乳腺癌前病变发展程度的客观标志  相似文献   
37.
目的 探讨军人花粉症治疗的有效方法。方法 采用提高起始浓度和快速递增浓度 ,上臂外侧皮下注射的方法对 10 6位军人花粉症患者行快速免疫治疗 ,并对每一位患者治疗前后检测血清中总IgE和嗜酸细胞阳离子蛋白 (ECP)。 结果 治疗前后患者总IgE和ECP值有显著性差异。 10 6例患者经 1~ 3年随访复查 ,78例 2个以上发病季节未发作 ,或仅有轻微鼻痒、眼痒 ,18例症状减轻 ,发病时间缩短半月 ,10例症状无明显改善。显效 82例 ,有效 14例 ,无效 10例 ,总有效率为 90 .5 7%。结论 快速免疫治疗能使患者血清总IgE和ECP下降 ,对军人花粉症疗效好。  相似文献   
38.
OBJECTIVE: To evaluate the clinical application of microsurgical fascia latae flaps combined with rib and skin graft for reconstruction of the distal phalanx defect. METHODS: The phalanx wounds were sutured together like syndactyly. The autologeous rib was revised to repair the bone defect of distal phalanx. The fascia latae flap was used to cover the bone exposure with microvascular anastomoses and resurfaced by a meshed split-thickness skin graft. RESULTS: 5 cases were treated successfully. The fascia latae flaps were all survived with only skin graft necrosis at the distal end in one case. It was healed spontaneously. CONCLUSIONS: The fascia latae flap is nourished by the desending branch of the lateral circumflex femoral artery. The flaps has a good blood supply and can be easily obtained with a long vascular pedicle. The flap is ideal for the reconstruction of distal phalanx defect when combined with autologeous rib implant and skin graft.  相似文献   
39.
BACKGROUND AND PURPOSE: Gastrointestinal stromal tumors (GISTs), identified by the presence of CD117 (KIT), were previously classified as gastric and intestinal smooth muscle tumors prior to the availability of immunohistochemical methods. This study evaluated the percentage of GISTs previously diagnosed as gastric smooth muscle tumors in our hospital during an 11-year period. METHODS: A total of 81 surgically resected gastric smooth muscle tumor specimens from 81 patients were collected from January 1986 to December 1997. Immunohistochemical studies were performed on these tumors with antibodies of CD34, CD117, smooth muscle actin (SMA), S-100, and desmin. RESULTS: Among the 81 tumors, 74 (91.4%) were CD117-positive and were classified as GISTs. Among the 74 GISTs, CD34 was positive in 72 tumors (97.3%), SMA was positive in 12 tumors (16.2%), desmin was positive in 5 tumors (6.7%), and S-100 was positive in 4 tumors (5.4%). The 7 tumors classified as non-GISTs had the following immunohistochemical characteristics: 1 was a CD117-negative CD34-positive stromal tumor (GINST) [1/81, 1.2%]; 3 were schwannomas with strong S-100-positive characteristics (3/81, 3.7%); and 3 were smooth muscle tumors with both SMA- and desmin-positive status (3/81, 3.7%). No clear relationship between CD117 or CD34 expression and prognosis was found for these tumors. CONCLUSIONS: The majority (91.4%) of gastric tumors originally diagnosed as gastric smooth muscle tumors were GISTs, except for small groups of smooth muscle tumors and schwannomas.  相似文献   
40.
In response to traumatic brain injury (TBI), neurons initiate neuroplastic processes through the activation of intracellular signaling pathways. However, the molecular mechanisms underlying neuroplasticity after TBI are poorly understood. To study this, we utilized the fluid-percussion brain injury (FPI) model to investigate alterations in the mammalian target of rapamycin (mTOR) signaling pathways in response to TBI. Mammalian target of rapamycin stimulates mRNA translation through phosphorylation of eukaryotic initiation factor 4E binding protein-1 (4E-BP1), p70 ribosomal S6 kinase (p70S6K), and ribosomal protein S6 (rpS6). These pathways coordinate cell growth and neuroplasticity via dendritic protein synthesis. Rats received sham surgery or moderate parasagittal FPI on the right side of the parietal cortex, followed by 15 mins, 30 mins, 4 h, 24 h, or 72 h of recovery. Using Western blot analysis, we found that mTOR, p70S6K, rpS6, and 4E-BP1 phosphorylation levels were significantly increased in the ipsilateral parietal cortex and hippocampus from 30 mins to 24 h after TBI, whereas total protein levels were unchanged. Using confocal microscopy to localize these changes, we found that rpS6 phosphorylation was increased in the parietal cortex and all subregions of the hippocampus. In accordance with these results, eIF4E, a key, rate-limiting mRNA translation factor, was also phosphorylated by mitogen-activated protein kinase-interacting kinase 1 (Mnk1) 15 mins after TBI. Together, these results suggest that changes in mRNA translation may be one mechanism that neurons use to respond to trauma and may contribute to the neuroplastic changes observed after TBI.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号